Sep 30

Scientific

SS 31 - Breast Cancer 3: Refining Radiation in Early-Stage Breast Cancer: Personalization, Precision, and De-escalation

Room 24

08:00am - 09:00am PT

MODERATOR(S)

Stephen Shiao, MD, PhD - Cedars-Sinai Medical Center

Diane Ling, MD - University of Pittsburgh Cancer Institute

Credits

AMA PRA Category 1 Credits:

1.00

Presentations

08:00am - 08:10am PT

Utilization of a Lumpectomy Bed Boost after Whole Breast Radiotherapy Does Not Improve Ipsilateral Breast Tumor Recurrence Risk in Patients with Ductal Carcinoma In-Situ Treated on Three NSABP Trials

Speaker: Atif Khan, MD, MS - Memorial Sloan Kettering Cancer Center, New York
08:10am - 08:20am PT

Phase I Pre-Operative Single Fraction Dose Escalation Ablative Stereotactic Partial Breast Irradiation (S-PBI) Trial for Early-stage Breast Cancer

Speaker: Asal Rahimi, MD, MS - University of Texas Southwestern Medical Center at Dallas, Dallas
08:20am - 08:30am PT

An Update of a Phase II Trial of Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-Risk Breast Cancer (UNIQUE)

Speaker: Hao Jing, MD - CAMS, Beijing
08:30am - 08:40am PT

Early-Stage Breast Cancer with Low Genomic Risk: Optimizing Adjuvant Therapy

Speaker: David Miller, MD, MS - Memorial Sloan Kettering Cancer Center, New York
08:40am - 08:50am PT

Prognostic Significance of Lymph Node Tumor Deposit Size in Early-Stage Breast Cancer

Speaker: Diana Roth O'Brien, MD - Memorial Sloan Kettering Cancer Center, New York
08:50am - 09:00am PT

Discussant

Speaker: Beryl McCormick, MD, FASTRO - Memorial Sloan Kettering Cancer Center, New York